+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Combination Vaccines Market 2025-2029- Product Image
Human Combination Vaccines Market 2025-2029- Product Image
New

Human Combination Vaccines Market 2025-2029

  • PDF Icon

    Report

  • 222 Pages
  • May 2025
  • Region: Global
  • TechNavio
  • ID: 5136985
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The human combination vaccines market is forecasted to grow by USD 7.72 billion during 2024-2029, accelerating at a CAGR of 8.8% during the forecast period. The report on the human combination vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing antiviral drug resistance, increase in pediatric population, and rise in cases of infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The human combination vaccines market is segmented as below:

By Type

  • Inactivated vaccine
  • Live attenuated vaccine

By Channel

  • Hospitals
  • Retailers
  • Online

By Route Of Administration

  • Intramuscular
  • Subcutaneous
  • Oral
  • Intradermal
  • Nasal spray

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the threat from bioterrorism as one of the prime reasons driving the human combination vaccines market growth during the next few years. Also, growing interest in research and development of new vaccines and presence of government-sponsored programs will lead to sizable demand in the market.

The report on the human combination vaccines market covers the following areas:

  • Human Combination Vaccines Market sizing
  • Human Combination Vaccines Market forecast
  • Human Combination Vaccines Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human combination vaccines market vendors that include Arabio, AstraZeneca Plc, Bharat Biotech Ltd., Biological E. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Grifols SA, LG Corp., Meiji Holdings Co. Ltd., Merck and Co. Inc., Mitsubishi Chemical Group Corp., Panacea Biotec Ltd., Pfizer Inc., PT Bio Farma, Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., Walvax Biotechnology Co. Ltd., and Zydus Lifesciences Ltd. Also, the human combination vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Channel
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Human Combination Vaccines Market 2019 - 2023
Historic Market Size - Data Table on Global Human Combination Vaccines Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Channel segment analysis 2019 - 2023
Historic Market Size - Channel Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Human Combination Vaccines Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Inactivated vaccine - Market size and forecast 2024-2029
Chart on Inactivated vaccine - Market size and forecast 2024-2029 ($ million)
Data Table on Inactivated vaccine - Market size and forecast 2024-2029 ($ million)
Chart on Inactivated vaccine - Year-over-year growth 2024-2029 (%)
Data Table on Inactivated vaccine - Year-over-year growth 2024-2029 (%)
8.4 Live attenuated vaccine - Market size and forecast 2024-2029
Chart on Live attenuated vaccine - Market size and forecast 2024-2029 ($ million)
Data Table on Live attenuated vaccine - Market size and forecast 2024-2029 ($ million)
Chart on Live attenuated vaccine - Year-over-year growth 2024-2029 (%)
Data Table on Live attenuated vaccine - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Channel
9.1 Market segments
Chart on Channel - Market share 2024-2029 (%)
Data Table on Channel - Market share 2024-2029 (%)
9.2 Comparison by Channel
Chart on Comparison by Channel
Data Table on Comparison by Channel
9.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
9.4 Retailers - Market size and forecast 2024-2029
Chart on Retailers - Market size and forecast 2024-2029 ($ million)
Data Table on Retailers - Market size and forecast 2024-2029 ($ million)
Chart on Retailers - Year-over-year growth 2024-2029 (%)
Data Table on Retailers - Year-over-year growth 2024-2029 (%)
9.5 Online - Market size and forecast 2024-2029
Chart on Online - Market size and forecast 2024-2029 ($ million)
Data Table on Online - Market size and forecast 2024-2029 ($ million)
Chart on Online - Year-over-year growth 2024-2029 (%)
Data Table on Online - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Channel
Market opportunity by Channel ($ million)
Data Table on Market opportunity by Channel ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
10.3 Intramuscular - Market size and forecast 2024-2029
Chart on Intramuscular - Market size and forecast 2024-2029 ($ million)
Data Table on Intramuscular - Market size and forecast 2024-2029 ($ million)
Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
10.4 Subcutaneous - Market size and forecast 2024-2029
Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
10.5 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.6 Intradermal - Market size and forecast 2024-2029
Chart on Intradermal - Market size and forecast 2024-2029 ($ million)
Data Table on Intradermal - Market size and forecast 2024-2029 ($ million)
Chart on Intradermal - Year-over-year growth 2024-2029 (%)
Data Table on Intradermal - Year-over-year growth 2024-2029 (%)
10.7 Nasal spray - Market size and forecast 2024-2029
Chart on Nasal spray - Market size and forecast 2024-2029 ($ million)
Data Table on Nasal spray - Market size and forecast 2024-2029 ($ million)
Chart on Nasal spray - Year-over-year growth 2024-2029 (%)
Data Table on Nasal spray - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
15.5 Bharat Biotech Ltd.
Bharat Biotech Ltd. - Overview
Bharat Biotech Ltd. - Product / Service
Bharat Biotech Ltd. - Key offerings
SWOT
15.6 Biological E. Ltd.
Biological E. Ltd. - Overview
Biological E. Ltd. - Product / Service
Biological E. Ltd. - Key news
Biological E. Ltd. - Key offerings
SWOT
15.7 CSL Ltd.
CSL Ltd. - Overview
CSL Ltd. - Business segments
CSL Ltd. - Key news
CSL Ltd. - Key offerings
CSL Ltd. - Segment focus
SWOT
15.8 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key offerings
SWOT
15.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
15.10 Grifols SA
Grifols SA - Overview
Grifols SA - Business segments
Grifols SA - Key news
Grifols SA - Key offerings
Grifols SA - Segment focus
SWOT
15.11 LG Corp.
LG Corp. - Overview
LG Corp. - Business segments
LG Corp. - Key news
LG Corp. - Key offerings
LG Corp. - Segment focus
SWOT
15.12 Meiji Holdings Co. Ltd.
Meiji Holdings Co. Ltd. - Overview
Meiji Holdings Co. Ltd. - Business segments
Meiji Holdings Co. Ltd. - Key offerings
Meiji Holdings Co. Ltd. - Segment focus
SWOT
15.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.14 Mitsubishi Chemical Group Corp.
Mitsubishi Chemical Group Corp. - Overview
Mitsubishi Chemical Group Corp. - Business segments
Mitsubishi Chemical Group Corp. - Key news
Mitsubishi Chemical Group Corp. - Key offerings
Mitsubishi Chemical Group Corp. - Segment focus
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.17 Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. - Overview
Serum Institute of India Pvt. Ltd. - Product / Service
Serum Institute of India Pvt. Ltd. - Key offerings
SWOT
15.18 Zydus Lifesciences Ltd.
Zydus Lifesciences Ltd. - Overview
Zydus Lifesciences Ltd. - Business segments
Zydus Lifesciences Ltd. - Key news
Zydus Lifesciences Ltd. - Key offerings
Zydus Lifesciences Ltd. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Human Combination Vaccines Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Channel Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Type
Exhibits 41: Data Table on Comparison by Type
Exhibits 42: Chart on Inactivated vaccine - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Inactivated vaccine - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Inactivated vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Inactivated vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Live attenuated vaccine - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Live attenuated vaccine - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Live attenuated vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Live attenuated vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 50: Market opportunity by Type ($ million)
Exhibits 51: Data Table on Market opportunity by Type ($ million)
Exhibits 52: Chart on Channel - Market share 2024-2029 (%)
Exhibits 53: Data Table on Channel - Market share 2024-2029 (%)
Exhibits 54: Chart on Comparison by Channel
Exhibits 55: Data Table on Comparison by Channel
Exhibits 56: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 60: Chart on Retailers - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Retailers - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Retailers - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Retailers - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Online - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Online - Year-over-year growth 2024-2029 (%)
Exhibits 68: Market opportunity by Channel ($ million)
Exhibits 69: Data Table on Market opportunity by Channel ($ million)
Exhibits 70: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 71: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 72: Chart on Comparison by Route of Administration
Exhibits 73: Data Table on Comparison by Route of Administration
Exhibits 74: Chart on Intramuscular - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Intramuscular - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Intradermal - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Intradermal - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Intradermal - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Intradermal - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Nasal spray - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Nasal spray - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Nasal spray - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Nasal spray - Year-over-year growth 2024-2029 (%)
Exhibits 94: Market opportunity by Route of Administration ($ million)
Exhibits 95: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 97: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 99: Chart on Geographic comparison
Exhibits 100: Data Table on Geographic comparison
Exhibits 101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 157: Market opportunity By Geographical Landscape ($ million)
Exhibits 158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 159: Impact of drivers and challenges in 2024 and 2029
Exhibits 160: Overview on criticality of inputs and factors of differentiation
Exhibits 161: Overview on factors of disruption
Exhibits 162: Impact of key risks on business
Exhibits 163: Companies covered
Exhibits 164: Company ranking index
Exhibits 165: Matrix on companies position and classification
Exhibits 166: AstraZeneca Plc - Overview
Exhibits 167: AstraZeneca Plc - Product / Service
Exhibits 168: AstraZeneca Plc - Key news
Exhibits 169: AstraZeneca Plc - Key offerings
Exhibits 170: SWOT
Exhibits 171: Bharat Biotech Ltd. - Overview
Exhibits 172: Bharat Biotech Ltd. - Product / Service
Exhibits 173: Bharat Biotech Ltd. - Key offerings
Exhibits 174: SWOT
Exhibits 175: Biological E. Ltd. - Overview
Exhibits 176: Biological E. Ltd. - Product / Service
Exhibits 177: Biological E. Ltd. - Key news
Exhibits 178: Biological E. Ltd. - Key offerings
Exhibits 179: SWOT
Exhibits 180: CSL Ltd. - Overview
Exhibits 181: CSL Ltd. - Business segments
Exhibits 182: CSL Ltd. - Key news
Exhibits 183: CSL Ltd. - Key offerings
Exhibits 184: CSL Ltd. - Segment focus
Exhibits 185: SWOT
Exhibits 186: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 187: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 188: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 189: SWOT
Exhibits 190: GlaxoSmithKline Plc - Overview
Exhibits 191: GlaxoSmithKline Plc - Business segments
Exhibits 192: GlaxoSmithKline Plc - Key news
Exhibits 193: GlaxoSmithKline Plc - Key offerings

Executive Summary

The following companies are recognized as the key players in the global human combination vaccines market: Arabio, AstraZeneca Plc, Bharat Biotech Ltd., Biological E. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Grifols SA, LG Corp., Meiji Holdings Co. Ltd., Merck and Co. Inc., Mitsubishi Chemical Group Corp., Panacea Biotec Ltd., Pfizer Inc., PT Bio Farma, Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., Walvax Biotechnology Co. Ltd., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is threat from bioterrorism."

According to the report, one of the major drivers for this market is the increasing antiviral drug resistance.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Arabio
  • AstraZeneca Plc
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Grifols SA
  • LG Corp.
  • Meiji Holdings Co. Ltd.
  • Merck and Co. Inc.
  • Mitsubishi Chemical Group Corp.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • PT Bio Farma
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Walvax Biotechnology Co. Ltd.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Tetanus Toxoid Vaccine Market 2024-2028 - Product Image

Tetanus Toxoid Vaccine Market 2024-2028

  • Report
  • 131 Pages
  • Global
From
Influenza Vaccine Market 2024-2028 - Product Image

Influenza Vaccine Market 2024-2028

  • Report
  • 168 Pages
  • Global
From
Pediatric Vaccine Market Opportunities and Strategies to 2033 - Product Image

Pediatric Vaccine Market Opportunities and Strategies to 2033

  • Report
  • 286 Pages
  • Global
From
Multivalent Vaccines Market 2024 - Product Image

Multivalent Vaccines Market 2024

  • Report
  • 175 Pages
  • Global
From
Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032 - Product Image

Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.